Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach
{{output}}
Introduction: Medical management of juvenile idiopathic arthritis (JIA) presents a significant challenge in pediatric rheumatology. Ideally, the treatment target is remission, though achieving this remains complex. Interleukin-6 ... ...
